<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Owners report improved quality of life for dogs treated with Librela and Solensia</title><link>/b/veterinary-news/posts/owners-report-improved-quality-of-life-for-dogs-treated-with-librela-and-solensia</link><description> Zoetis has presented the results of two studies looking at the impact of Librela (bedinvetmab) and Solensia (frunevetmab) on the quality of life (QoL) of dogs and cats with osteoarthritis (OA). 
 For the studies, the owners of 68 dogs treated with Librela</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>